Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide

Hypertension Research

Volumn 23, Issue 4, 2000, Pages 377-380

  Hua, Liyan ^a   Li, Changyu ^a   Xia, Daozi ^a   Qu, Peng ^a   Li, Zhongyan ^a   Zhang, Weijiang ^a   Feng, Xiaohai ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Endothelin; Hypertension; Left ventricular hypertrophy; Nitric oxide

Indexed keywords

ENDOTHELIN; NITRIC OXIDE;

ADULT; AGE; AGED; BLOOD LEVEL; BODY MASS; CONFERENCE PAPER; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENDER; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTIPLE REGRESSION; PATHOGENESIS;

EID: 0033935169     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.23.377     Document Type: Conference Paper

References (15)

1. Nakashima Y, Found FM, Farazi RC: Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 1984; 53: 1044-1049.
2. Tamirisa P, Frishman WH, Kumar A: Endothelin and endothelin antagonism: roles in cardiovascular health and disease. Am Heart J 1995; 130: 601-610.
3. Matsuoka H, Nakata M, Kohno K, Koya Y, Namura G, Toshima H: Chronic L-arginine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 1996; 27: 14-18.
4. Devereux RB, Alonso DR, Lutas EM, Gottlied GJ, Reichek N: Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
5. Liu GZ, Dang AM: The Mechanism, Diagnosis and Treatment of Hypertensive LVH. J Chin Circ 1998; 13: 2-3.
6. Laririere R, Dey R: Increased expression of endothelin-1 gene in blood vessels of deoxy corticosterone acetate salt hypertensive rats. Hypertension 1993; 21: 916.
7. Bunchman TE, Brookshire CA: Cyclosporine induced synthesis of endothelin by cultured human endothelia cells. J Clin Invest 1991; 88: 310-314.
8. Ito H, Hirata Y, Hiroe M: ET-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured neonatal rat cardiomyocytes. Circ Res 1991; 69: 209-215.
9. Ito H, Hiroe M, Hirata Y, Tsujino M, Shichiri M: Insulin-like growth factor-1 induces cardiac hypertrophy with enhanced expression of muscle-specific genes in cultured rat cardiomyocytes. Circulation 1993; 87: 1715-1721.
10. Karam H, Heudes D, Hess P: Role of endothelin in cardiac remodeling in DOCAA hypertensive rats. Circulation 1994; 90: 1-261 (Abstract).
11. Marshall JJ, Kontos HA: Endothelium derived relaxing factors. Hypertension 1990; 16: 371.
12. Arnal JF, Battle T, Menard J, Michel JB: The vasodilatory effect of endogenous nitric oxide is a major counterregulatory mechanism in the spontaneously hypertensive rat. J Hypertens 1993; 11: 945-950.
13. Kolpakov V, Gordon D, Kulik TJ: Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res 1995; 762: 305-309.
14. Tang CS, Tian Q, Tang J: The Study of the Relation between EDRF/NO and EDCF/ET, Physiol Correspond Suppl; 1994; 28-31.
15. Luscher TF: Imbalance of endothelium derived relaxing and contracting factors: a new concept in hypertension. Am J Hypertens 1990; 3: 317-320.